About 1,646,563 results (2,043 milliseconds)

Post-Onset Shingles Rx Fails to Cut Ischemic Stroke Risk

http://feedproxy.google.com/~r/Theheartorg/~3/oX202agEhgc/908574
Feb 1, 2019 ... Receiving a herpes zoster (HZ) vaccination, antiviral therapy, or ... Acute ischemic stroke risk spiked 61% within 14 days of shingles ...

US20130172282A1 - Method of treating herpes virus infection using ...

https://patents.google.com/patent/US20130172282A1/en
It is until recent years, two vaccines for varicella zoster virus ... Antiviral drug treatment can reduce the severity and duration of herpes zoster ...

US5213798A - Antiviral agent derived from the hull of the kukui nut ...

https://patents.google.com/patent/US5213798A/en
... herpes zoster, for several days or until needed. A process for obtaining an antiviral pharmaceutical agent composition, includes following steps: obtaining ...

US6936288B2 - Method and composition for the treatment of ...

https://patents.google.com/patent/US6936288B2/en
More particularly, the invention relates the treatment of shingles and PHN with anti-viral proteins extracted from pokeweed plants. ... medicine is applied 4 ...

CN103263426A - New use of gentamicin sulfate as medicament for ...

https://patents.google.com/patent/CN103263426A/en
Treatment antiviral drugs commonly used is acyclovir, valaciclovir ... The gentamycin sulfate tablets agent is as the medicine for the treatment of herpes zoster ...

US8735377B1 - Methods of treating herpes zoster - Google Patents

https://patents.google.com/patent/US8735377B1/en
May 27, 2014 ... The doctor also prescribed VALTREX®, an antiherpetic medication, in a dose of a 1 gram tablet, taken 3 times a day for 7 days. The doctor ...

CN103599522A - Traditional Chinese medicine preparation for ...

https://patents.google.com/patent/CN103599522A/en
Herpes zoster is the actute infection dermatoses being caused by varicella zoster virus.This virus has neurotropism, after infection, can hide for a long time ...

CN104906220A - Traditional Chinese medicine for treating herpes ...

https://patents.google.com/patent/CN104906220A/en
... medicine for the treatment of herpes zoster and herpes simplex keratitis. ... antiviral traditional Chinese medicine compound. CN104013728A * 2014-06-30 ...

US8492362B1 - 5-(E)-Bromovinyl uracil analogues and related ...

https://patents.google.com/patent/US8492362B1/en
... herpes zoster (shingles). VZV ... In HFFs, 100 μM L-BHDU was noncytotoxic over 3 days, and the antiviral effects of 2 μM treatment were reversible by XXX.

CN1251736C - Chinese medicinal infusion for treating shingles ...

https://patents.google.com/patent/CN1251736C/en
... treatments such as acyclovir cream outward, and is invalid ... days, had reduced the treatment sequela of herpes zoster---neuralgic generation effectively.

US8492362B1 - 5-(E)-Bromovinyl uracil analogues and related ...

https://patents.google.com/patent/US8492362B1/en
... herpes zoster (shingles). VZV ... In HFFs, 100 μM L-BHDU was noncytotoxic over 3 days, and the antiviral effects of 2 μM treatment were reversible by XXX.

EP1850670A1 - Formulations useful for the treatment of varicella ...

https://patents.google.com/patent/EP1850670A1/en
Antiviral drugs, principally the nucleoside analogs, can lessen the duration of shingles and lower the risk of PHN, especially if taken within three days of the ...

EP2490683B1 - Diclofenac for treating herpes virus infections ...

https://patents.google.com/patent/EP2490683B1/en
Acyclovir is in a class of antiviral medications called synthetic nucleoside analogues. ... days or until the specific event achieved, whichever comes first.

US7862838B1 - Composition and regimen for the treatment of ...

https://patents.google.com/patent/US7862838B1/en
Jan 4, 2011 ... ... days, administer 1 capsule of said formula every 4 hours until ... antiviral agents) to treat herpes simplex and herpes zoster. The ...

US7618950B2 - Method for treatment and prevention of herpes ...

https://patents.google.com/patent/US7618950B2/en
The labeling for Zovirax (acyclovir) tablets describes clinical trials conducted in immunocompetent (but not immunocompromised) adults with herpes zoster.

US20060264423A1 - Methylene Blue Therapy of Viral Disease ...

https://patents.google.com/patent/US20060264423A1/en
However, long-term antiviral drug prophylaxis is not advisable in allograft ... All concomitant medication taken from 30 days prior to screening until the follow ...

US20150025152A1 - Formulation and method of use of a treatment ...

https://patents.google.com/patent/US20150025152A1/en
Jan 22, 2015 ... Before the rash develops, shingles sufferers often have pain ... Several antiviral medications help shorten the length and severity of ...

US20110206778A1 - Treatment For Neuropathy, Shingles And ...

https://patents.google.com/patent/US20110206778A1/en
Likewise, the percentage of zinc oxide can be varied to any suitable amount so long as its ability to be conveniently spread on skin surface, and to remain ...

US5677308A - Method for alleviating spasmodic torticollis - Google ...

https://patents.google.com/patent/US5677308A/en
Preferably, the antiviral agent administered is valacyclovir, marketed under the trademark Valtrex® by the Burroughs Wellcome Company. Valacyclovir is the L- ...